Inventor · disambiguated record
Yasuhiro Aga
Also filed as: AGA YASUHIRO
6 granted patents·6 pending applications·3 citations·filing 2008–2023
69Inventor score
Top patents by PatentIndex Score
12 records- 0184US10273252B2Substituted dihydropyrrolopyrazole derivativeUBE INDUSTRIES·Filed 2016·Granted Apr 30, 2019·3 cites·33 claims
- 0262US10894798B2Substituted dihydropyrrolopyrazole derivativeUBE INDUSTRIES·Filed 2019·Granted Jan 19, 2021·0 cites·14 claims
- 0361US2025325689A1Antibody-multidrug conjugateUBE CORP·Filed 2023·Application pending·0 cites
- 0460US2025235547A1Antibody-drug conjugateUBE CORP·Filed 2023·Application pending·0 cites
- 0559US11407831B2Pharmaceutical composition administered in combination with substituted dihydropyrrolopyrazole compound and immunotherapeutic agentUBE INDUSTRIES·Filed 2018·Granted Aug 9, 2022·0 cites·12 claims
- 0659US2023100534A1Pharmaceutical composition administered in combination with substituted dihydropyrrolopyrazole compound and immunotherapeutic agentUBE INDUSTRIES·Filed 2022·Application pending·0 cites
- 0758US2025049806A1Pharmaceutical composition for providing treatment for or preventing alport syndromeUBE CORP·Filed 2022·Application pending·0 cites
- 0851US10131679B2Substituted dihydropyrrolopyrazole compoundUBE INDUSTRIES·Filed 2015·Granted Nov 20, 2018·0 cites·39 claims
- 0951US2023192661A11, 4, 5, 6-tetrahydropyrimidine-2-amine derivativeUBE CORP·Filed 2021·Application pending·0 cites
- 1050US8377922B2Benzazepinone compoundUBE INDUSTRIES·Filed 2008·Granted Feb 19, 2013·0 cites·26 claims
- 1146US12304913B2Dihydropyrrolopyrazole derivativeUBE INDUSTRIES·Filed 2019·Granted May 20, 2025·0 cites·17 claims
- 1233US2012095215A1Medical composition for treatment or prophylaxis of eye diseasesHAGIHARA MASAHIKO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasuhiro Aga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →